Novartis
Search results
- Open35.00High35.54Low34.90
- Mkt Cap15.08BP/E (TTM)N/ADiv & Yield0.45 & 1.27%
- Prev. Close35.3552 Wk. Low22.7052 Wk. High38.52
Related stocks
Open | 35.00 |
High | 35.54 |
Low | 34.90 |
Mkt Cap | 15.08B |
P/E (TTM) | N/A |
Div & Yield | 0.45 & 1.27% |
Prev. Close | 35.35 |
52 Wk. Low | 22.70 |
52 Wk. High | 38.52 |
Related stocks
Pharmaceutical company
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 2.53B | 2.70% ▲ |
Net Income | 75M | 36.20% ▼ |
Diluted EPS | 36.20% ▼ |
S&P 500^GSPC | 5,561.85+7.72 (+0.14%) |
Dow 30^DJI | 40,821.99-39.72 (-0.10%) |
Nasdaq^IXIC | 17,455.26+59.73 (+0.34%) |
Moderna, Inc.MRNA | 66.12-16.84% |
86.91-4.13% | |
24.57-11.94% |